CR6300A - NEW ORAL FORMULATION - Google Patents

NEW ORAL FORMULATION

Info

Publication number
CR6300A
CR6300A CR6300A CR6300A CR6300A CR 6300 A CR6300 A CR 6300A CR 6300 A CR6300 A CR 6300A CR 6300 A CR6300 A CR 6300A CR 6300 A CR6300 A CR 6300A
Authority
CR
Costa Rica
Prior art keywords
oral formulation
new oral
composition
new
active agents
Prior art date
Application number
CR6300A
Other languages
Spanish (es)
Inventor
Bruijn Karel De
Gunter Engel
Hans Jurgen Pfannkuche
Michael Thewisen
Christian Vitzling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to CR6300A priority Critical patent/CR6300A/en
Publication of CR6300A publication Critical patent/CR6300A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica, en particular a una composición para administrar agentes activos que sean pobremente solubles en medios acuosos, y/o que sean sensibles al ácido.The present invention relates to a pharmaceutical composition, in particular to a composition for administering active agents that are poorly soluble in aqueous media, and / or that are acid sensitive.

CR6300A 2001-01-26 2001-01-26 NEW ORAL FORMULATION CR6300A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR6300A CR6300A (en) 2001-01-26 2001-01-26 NEW ORAL FORMULATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR6300A CR6300A (en) 2001-01-26 2001-01-26 NEW ORAL FORMULATION

Publications (1)

Publication Number Publication Date
CR6300A true CR6300A (en) 2004-06-08

Family

ID=51359471

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6300A CR6300A (en) 2001-01-26 2001-01-26 NEW ORAL FORMULATION

Country Status (1)

Country Link
CR (1) CR6300A (en)

Similar Documents

Publication Publication Date Title
CY1110906T1 (en) PHARMACEUTICAL COMPOSITION FOR NON-ADMINISTRATION OF FENTANYL
YU8701A (en) New oral formulation
AR033423A1 (en) PHARMACEUTICAL SALTS CONSTITUTED OF AN ACTIVE PHARMACEUTICAL SUBSTANCE AND AT LEAST A SWEETENER, MEDICATIONS CONTAINING THESE SALTS AND USE OF THESE SALTS FOR THE PREPARATION OF MEDICINES
AR032293A1 (en) PHARMACEUTICAL CASE
ATE541562T1 (en) IBUPROFEN SUSPENSION
NO20023551D0 (en) Ibuprofen-containing active agent preparation
DE69923336D1 (en) ORANGE BUPRENORPHINIC MEDICINAL PRODUCTS TO BE APPLIED
AR023815A1 (en) ORAL PRUCALOPRIDE SOLUTION
DE60111503D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TERBINAFIN
MXPA01011842A (en) PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ADMINISTRATION OF FLOROGLUCINOL AND PREPARATION OF THE SAME.
SE0001916D0 (en) Novel formulation
CR6300A (en) NEW ORAL FORMULATION
DK1273301T3 (en) Pharmaceuticals based on active ingredients that can be used for illicit administration
ECSP993104A (en) NEW ORAL FORMULATION
ATE357220T1 (en) MODIFIED RELEASE PHARMACEUTICAL COMPOSITION
DE60112578D1 (en) PHARMACEUTICAL DICLOFENAC COMPOUND BASED ON VITAMIN E, PAPAIN AND HYALURONIDASE
MY152490A (en) New oral formulation
NO20044519L (en) Hyperforin derivatives, their use and formulations containing them
EP1556022A4 (en) AQUEOUS PHARMACEUTICAL COMPOSITIONS 2,6-DIISOPROPYLPHENOL
HRP20070081T3 (en) NASAL PHARMACEUTICAL PREPARATION OF PIRIBEDIL